KM

Kelly Meunier

Senior Chemical Process Development Engineer at NorthStar Medical Radioisotopes, LLC

Kelly Meunier has a diverse work experience spanning multiple industries and roles. Since 2022, they have been working at NorthStar Medical Radioisotopes, LLC as a Senior Chemical Process Development Engineer, where they focus on developing GMP-compliant chemical processes for manufacturing radioisotopes. Before that, they worked at Vetter Pharma as a Senior Process Development Engineer from 2018 to 2022, and as a Process Development Engineer from 2018 to 2021. Prior to that, they worked at The Kraft Heinz Company as a Process Engineer from 2016 to 2018, and at Dow Corning as a Process Engineering Intern in 2015. Kelly also gained experience as an Undergraduate Teaching Assistant at the University of Minnesota Chemical Engineering and Materials Science Department in 2014, and as an Undergraduate Research Assistant at Argonne National Laboratory in the same year. Additionally, they worked as an Analytical Laboratory Intern at PCI - Packaging Coordinators Inc in 2013 and as an Assistant to the Golf Operations Manager at Rockford Park District from 2011 to 2012.

Kelly Meunier earned a Bachelor's Degree in Chemistry and Chemical Engineering from the University of Minnesota, where they studied from 2012 to 2016. Prior to that, they attended Boylan Catholic High School from 2008 to 2012, where they completed their high school education.

Location

Sun Prairie, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


NorthStar Medical Radioisotopes, LLC

NorthStar Medical Radioisotopes LLC (northstarnm.com) was founded in 2006 to address the needs of the nuclear medicine market in the United States. A wholly owned subsidiary of NorthStar Medical Technologies LLC, the company is committed to resolving industry-wide supply challenges that have caused shortages of vital medical isotopes, negativelyimpacting patient care and stalling clinical research. Its patented technologies include innovative non-uranium based molybdenum-99 production methods, a novel separation chemistry system and tools for the nuclear medicine market.


Employees

201-500

Links